Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1998 1
1999 1
2000 1
2001 2
2002 3
2003 2
2004 4
2005 6
2006 10
2007 3
2008 8
2009 10
2010 6
2011 7
2012 8
2013 8
2014 6
2015 6
2016 7
2017 11
2018 7
2019 4
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 19179427

101 results
Results by year
Filters applied: . Clear all
Page 1
Cerebral blood volume measurements by perfusion-weighted MR imaging in gliomas: ready for prime time in predicting short-term outcome and recurrent disease?
Bisdas S, Kirkpatrick M, Giglio P, Welsh C, Spampinato MV, Rumboldt Z. Bisdas S, et al. AJNR Am J Neuroradiol. 2009 Apr;30(4):681-8. doi: 10.3174/ajnr.A1465. Epub 2009 Jan 29. AJNR Am J Neuroradiol. 2009. PMID: 19179427 Free PMC article.
Correlation between cerebral blood volume measurements by perfusion-weighted magnetic resonance imaging and two-year progression-free survival in gliomas.
Spampinato MV, Schiarelli C, Cianfoni A, Giglio P, Welsh CT, Bisdas S, Rumboldt Z. Spampinato MV, et al. Neuroradiol J. 2013 Aug;26(4):385-95. doi: 10.1177/197140091302600404. Epub 2013 Aug 27. Neuroradiol J. 2013. PMID: 24007727 Free PMC article.
Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].
Lev MH, Ozsunar Y, Henson JW, Rasheed AA, Barest GD, Harsh GR 4th, Fitzek MM, Chiocca EA, Rabinov JD, Csavoy AN, Rosen BR, Hochberg FH, Schaefer PW, Gonzalez RG. Lev MH, et al. AJNR Am J Neuroradiol. 2004 Feb;25(2):214-21. AJNR Am J Neuroradiol. 2004. PMID: 14970020 Free article.
Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas.
Law M, Oh S, Johnson G, Babb JS, Zagzag D, Golfinos J, Kelly PJ. Law M, et al. Neurosurgery. 2006 Jun;58(6):1099-107; discussion 1099-107. doi: 10.1227/01.NEU.0000215944.81730.18. Neurosurgery. 2006. PMID: 16723889
Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response.
Law M, Oh S, Babb JS, Wang E, Inglese M, Zagzag D, Knopp EA, Johnson G. Law M, et al. Radiology. 2006 Feb;238(2):658-67. doi: 10.1148/radiol.2382042180. Epub 2006 Jan 5. Radiology. 2006. PMID: 16396838
Correlation between progression free survival and dynamic susceptibility contrast MRI perfusion in WHO grade III glioma subtypes.
Mangla R, Ginat DT, Kamalian S, Milano MT, Korones DN, Walter KA, Ekholm S. Mangla R, et al. J Neurooncol. 2014 Jan;116(2):325-31. doi: 10.1007/s11060-013-1298-9. Epub 2013 Nov 1. J Neurooncol. 2014. PMID: 24178441
Prognostic value of perfusion MR imaging in patients with oligodendroglioma: A survival study.
Jiang Z, Le Bas JF, Grand S, Salon C, Pasteris C, Hoffmann D, Bing F, Berger F, Chabardes S, Liu C, Krainik A. Jiang Z, et al. J Neuroradiol. 2011 Mar;38(1):53-61. doi: 10.1016/j.neurad.2010.03.004. Epub 2010 Jun 15. J Neuroradiol. 2011. PMID: 20554324
Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, Knopp EA, Zagzag D. Law M, et al. AJNR Am J Neuroradiol. 2003 Nov-Dec;24(10):1989-98. AJNR Am J Neuroradiol. 2003. PMID: 14625221 Free article.
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
Abrigo JM, Fountain DM, Provenzale JM, Law EK, Kwong JS, Hart MG, Tam WWS. Abrigo JM, et al. Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2. Cochrane Database Syst Rev. 2018. PMID: 29357120 Free PMC article. Review.
Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging.
Cha S, Tihan T, Crawford F, Fischbein NJ, Chang S, Bollen A, Nelson SJ, Prados M, Berger MS, Dillon WP. Cha S, et al. AJNR Am J Neuroradiol. 2005 Feb;26(2):266-73. AJNR Am J Neuroradiol. 2005. PMID: 15709123 Free article.
101 results
Jump to page
Feedback